Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living With Myelodysplastic Syndromes apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Article content
When women turn 50, they typically get two birthday cards from the province. One encourages them to schedule a routine mammogram. The other invites them to poop on a stick.
Surprisingly, it’s the stick many dread less.
We apologize, but this video has failed to load.
Try refreshing your browser. Baranyai: As COVID limits ease, undetected breast cancer crisis looms Back to video
The risk of breast and colon cancers increases after age 50. Cancer Care Ontario (now part of the mega-agency, Ontario Health) co-ordinates screening programs for early detection before symptoms arise.
Last winter, these vital screening services were paused, along with other scheduled procedures, as hospitals and labs freed up pandemic capacity. These were reasonable measures in uncertain times. When clinical screening resumed, however, women didn’t exactly flock back.
Date Time
Biotech company founded by University of Toronto researchers secures US$85 million in financing Juan Carlos Zúñiga-Pflücker (left), of the Temerty Faculty of Medicine and Sunnybrook Health Sciences Centre, and Peter Zandstra, who is now at UBC, founded Notch Therapeutics at U of T in 2018.
Notch was founded in 2018 by two pioneers of cell therapy research, Juan Carlos Zúñiga-Pflücker, chair of the department of immunology at the University of Toronto’s Temerty Faculty of Medicine and a senior scientist at Sunnybrook Health Sciences Centre, and Peter Zandstra, who was then at U of T and is now a professor at the University of British Columbia, but continues to collaborate with U of T’s Institute for Biomedical Engineering. The company was supported by MaRS Innovation (now Toronto Innovation Acceleration Partners) and the Centre for Commercialization of Regenerative Medicine.
COVID-19 vaccines are ‘ethically justified’ for pregnant women: CMAJ
Commentary issued by the Canadian Medical Association Journal says person s choice must be respected
Feb 7, 2021 7:00 PM By: Len Gillis, Local Journalism Initiative
(Stock)
Medical experts are saying pregnant and breastfeeding women should not be routinely offered COVID-19 vaccines until more data is gathered, but the same experts are saying it is ethically justified to offer the vaccines to those who want it.
The recommendation is part of a commentary recently published by the
Canadian Medical Association Journal (CMAJ) and said vaccines can be considered in certain scenarios where the benefits are deemed to outweigh the risks.
A nurse places a pulse oximeter to measure the oxygen level and heart rate of a man who is recovering from pneumonia at his home, Thursday, July 9, 2020, in Ipswich, Mass. One saving grace amid the devastation of COVID-19 pandemic has been that the vast majority of those infected are able to recover at home, allowing hospitals to cope with what would otherwise have been a system-crushing onslaught of ill, contagious patients.THE CANADIAN PRESS/AP/Elise Amendola TORONTO One saving grace amid the devastation of COVID-19 has been that the vast majority of those infected are able to recover at home, allowing hospitals to cope with what would otherwise have been a system-crushing onslaught of ill, contagious patients.